Fixed Drug Erythema in an older adult patient. Case presentation

Authors

Keywords:

older adult, amlodipine, aspirin, dermatology

Abstract

Fixed drug erythema is a secondary skin reaction to some drugs, so its pathogenic mechanism is not yet known. It is associated with the administration of several drugs; a history of antihypertensive medications is not recorded. It is clinically characterized by rounded erythematous lesions that, when involuted, leave residual blue-gray hypopigmented spots. The case of a 73-year-old patient who attended a dermatology consultation at the Joaquín Albarrán Surgical Clinical Teaching Hospital with disseminated erythematous-violaceous macules is presented, for whom the diagnosis of fixed drug erythema was made, highlighting the importance of timely diagnosis and treatment, which contribute to a favorable outcome, thereby reducing high costs, prolonged hospital stays, and potential mortality. He was prescribed treatment with corticosteroids, antihistamines, and an exclusion diet and consultation with internal medicine to change treatment. Reaching the conclusion that doctor in the PHC must take into account antihypertensive treatment in older adult patients and the risk of suffering from this dermatological disease.

Downloads

Download data is not yet available.

Author Biography

Bizmar Alejandro Frómeta Correa, Universidad de Ciencias Médicas Guantánamo

Estudiante de 5to año de Medicina. Alumno ayudante de Cardiología. Universidad de Ciencias Médicas de Guantán

References

1. Aguilar-Urbina EW, Plasencia-Meza C, Chávez-Rimarachín M, Aquino-Salverredy R, Velásquez-Ojeda A, Bazán-Gallo C, et al. Eritema pigmentado fijo ampolloso medicamentoso relacionado con el uso de ivermectina en paciente con neumonía por SARS-CoV-2: reporte de caso. Rev Cuerpo Med HNAAA [Internet]. 2021 [citado 10 Dic 2024];14(3):394-397. Disponible en: http://dx.doi.org/10.35434/rcmhnaaa.2021.143.1280

2. Núñez-Naranjo MM, Rodas-Espinoza AF. Exantema fijo medicamentoso generalizado. Medigraphic [Internet]. 2014 [citado 10 Dic 2024];42(1-3):54-56. Disponible en: https://www.medigraphic.com/pdfs/cutanea/mc-2014/mc141_3j.pdf

3. Esqueff-Díaz N, Sierra-Díaz D, Pérez-Báez N. Eritema fijo medicamentoso múltiple: reporte de caso. Medimay [Internet]. 2024 [citado 10 Dic 2024];31(2):6-9. Disponible en: https://revcmhabana.sld.cu/index.php/rcmh/article/view/2439

4. Rojas-Caraballo N, Machado-Mora Y, Lagos-Ordoñez KJ, Bordelois-Abdo JA, Mozo-Bigñotte A. Reacciones cutáneas adversas medicamentosas en el Hospital General Docente «Dr. Agostinho Neto», Guantánamo 2018-2019. Rev Inf Cient [Internet]. 2020 [citado 10 Dic 2024];99(2):10-14. Disponible en: https://revinfcientifica.sld.cu/index.php/ric/article/view/2811

5. Choi H, Ku J, Kim M, Kang H, Cho S, Kim H, et al. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption. Br J Dermatol [Internet]. 2006 [citado 10 Dic 2024];155(4):419-425. Disponible en: https://doi.org/10.1111/j.1365-2133.2005.07057.x

6. Academia Española de Dermatología y Venereología. Eritema fijo medicamentoso [Internet]. Madrid: Fundación Piel Sana; 2017 [citado 10 Dic 2024]. Disponible en: https://aedv.fundacionpielsana.es/wikiderma/eritema-fijo-medicamentoso/

7. Pérez-Pérez L, García-Gavilán J, Allegue-Zulaica A. Exantema fijo medicamentoso múltiple probablemente inducido por ácido mefenámico. Actas Dermosifiliogr [Internet]. 2013 [citado 10 Dic 2024];104(1):85-87. Disponible en: https://www.actasdermo.org/es-exantema-fijo-medicamentoso-multiple-probablemente-articulo-S0001731012002694

8. Salcido-de Pablo PA, Urrutia-Guerrero JS, Valdés-Castañeda SL, et al. Farmacodermia por amlodipino: reporte de un caso. Med Int Mex [Internet]. 2013 [citado 10 Dic 2024];29(3):327-330. Disponible en: https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=41864

9. Pérez-López A, Gómez-Vélez VC, Cardozo-Lunar NA. Dermatosis más frecuentes en pacientes geriátricos atendidos en dos centros de asistencia médica. Arch Hosp Univ Gen Calixto García [Internet]. 2019 [citado 8 Dic 2024];7(3):9-18. Disponible en: https://revcalixto.sld.cu/index.php/ahcg/article/view/404

10. Kidon M, Blanca-Lopez N, Gomes E, Terreehorst I, Tanno L, Ponvert C, et al. EAACI/ENDA position paper: diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (AINEs) in children and adolescents. Pediatr Allergy Immunol [Internet]. 2018 [citado 19 Dic 2024];29(5):469-480. Disponible en: https://doi.org/10.1111/pai.12915

11. Fustá-Novell X, Bosch-Amate X, Morgado-Carrasco D. Eritema fijo medicamentoso. Aten Primaria Pract [Internet]. 2019 [citado 19 Dic 2024];1(3):55-56. Disponible en: https://doi.org/10.1016/j.appr.2019.02.002

12. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Helsinki: World Medical Association; 1964.

Published

2026-09-08

How to Cite

1.
Frómeta Correa BA, Cosera Arias M, Ferrales Isalgué VM. Fixed Drug Erythema in an older adult patient. Case presentation. UNIMED [Internet]. 2026 Sep. 8 [cited 2026 Sep. 10];8(1). Available from: https://revunimed.sld.cu/index.php/revestud/article/view/413

Issue

Section

Casos Clínicos